High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level

被引:0
作者
Chunsen Xu
Mutsuko Yamamoto-Ibusuki
Yutaka Yamamoto
Satoko Yamamoto
Saori Fujiwara
Keiichi Murakami
Yasuhiro Okumura
Lisa Yamaguchi
Yoshitaka Fujiki
Hirotaka Iwase
机构
[1] Kumamoto University,Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences
[2] Fujian Medical University,Department of Breast Surgery, Affiliated Union Hospital
来源
Breast Cancer | 2014年 / 21卷
关键词
Survivin; Breast cancer; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:482 / 490
页数:8
相关论文
共 193 条
[1]  
Autier P(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-717
[2]  
Boniol M(2010)Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database BMJ 341 3620-3627
[3]  
La Vecchia C(2010)ACP Journal Club. Review: in women 39 to 69 years of age, screening with mammography reduces breast cancer mortality Ann Intern Med 152 727-737
[4]  
Vatten L(2008)The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine Drug Discov Today 13 481-487
[5]  
Gavin A(2008)Advances in breast cancer: pathways to personalized medicine Clin Cancer Res 14 7988-7999
[6]  
Hery C(2009)The HER-2 receptor and breast cancer: 10 years of targeted anti-HER-2 therapy and personalized medicine Oncologist 14 320-368
[7]  
Willett LR(2011)Innovative biomarker development for personalized medicine in breast cancer care Biomark Med 5 73-78
[8]  
Foekens JA(2006)Challenges in the stratification of breast tumors for tailored therapies Bull Cancer 93 E81-E89
[9]  
Wang Y(2010)A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤ 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment? Breast Cancer Res Treat 119 653-61
[10]  
Martens JW(2011)Survivin expression and targeting in breast cancer Surg Oncol 27 6276-6284